Pharma Data Mining Restriction Options Available
But doctors and others say that such practices boost the sale of more expensive brand-name drugs, thereby raising healthcare costs, and jeopardizes patient safety by promoting new drugs about which safety and efficacy data are limited, Mello and Messing wrote. It also may violate patient and physician privacy.
The Vermont law, which the court struck down in Sorrell v. IMS Health, Inc. on grounds that it violated the right to free speech, prohibited pharmacies and PDIs from selling, licensing, or exchanging prescriber drug information or using it to promote pharmaceutical products. Two similar laws in Maine and New Hampshire are expected to be challenged or to fall next as a result of the high court ruling.
The AMA allows doctors to exercise the AMA's Physician Data Restriction Program, which allows doctors to withhold their prescribing practice data from the pharmaceutical sales reps.
However, to date, Mello and Messing wrote, "few physicians (approximately 4%) have signed up for the PDRP, perhaps because the AMA's financial interests cut against strongly promoting the program. The AMA realizes substantial revenue from the sale of physicians' professional data, and widespread physician opt-out would reduce the usefulness of the data to PDIS."
Asked for a comment, a spokesman for the AMA declined, but sent its June 23 statement, issued after the Supreme Court ruling in the Vermont case. That statement urged doctors who don't want their data shared with pharmaceutical detailers to use the PDRP.
- CEO Exchange: Preparing for Population Health
- Advocate, NorthShore Deal Would Create 16-Hospital System
- Better HCAHPS Scores Protect Revenue
- Narrow Networks Cut Costs, Not Quality, Economists Say
- 3 Strategies for Retaining Millennial Employees
- Power of price: In South FL and the nation, healthcare costs often are shrouded in secrecy
- Two NY hospitals to offer free hip and knee replacement surgeries for qualifying patients in December
- Hospital mergers may lead to higher prices
- Healthcare data of 1 million NJ patients compromised since 2009
- 'Early Offer' Malpractice Programs May Spur Reform